Abstract
The antimicrobial activity of 19 propolis extracts prepared in different solvents (ethanol and propylene glycol) (EEP/PEP), was evaluated against some bacterial and fungal isolates using the agar-well diffusion method. It was verified that all the samples tested showed antimicrobial activity, although results varied considerably between samples. Results revealed that both types of propolis extracts showed highly sensitive antimicrobial action against Gram-positive bacteria and fungi at a concentration of 20% (Staphylococcus aureus, Streptococcus mutans, Candida albicans and Saccharomyces cerevisae) with a minimal inhibitory concentration (MIC) ranging from 0.5 to 1.5 mg/ml, with a moderate effect against Streptococcus pyogenes (MIC from 17 to 26 mg/ml). To our knowledge, this is the first study showing elevated antimicrobial activity against Gram-negative bacteria [Salmonella enterica (MIC from 0.6 to 1.4 mg/ml)] and lesser activity against Helicobacter pylori (MIC from 6 to 14 mg/ml), while Escherichia coli was resistant. This concluded that the Basque propolis had a strong and dose-dependent activity against most of the microbial strains tested, while database comparison revealed that phenolic substances were responsible for this inhibition, regardless of their geographical origin and the solvent employed for extraction. Statistical analysis showed no significant differences (P ≤ 0.05) between EEP and PEP extracts.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Propolis is a resinous mixture that honeybees collect from tree buds, sap flows, and other botanical sources. This resin is masticated, salivary enzymes added, and the partially digested material is mixed with beeswax and used in the hive. Chemical analyses have showed the presence of beeswax at between 2 and 30%, and vegetable resins at between 40 and 80% in propolis powder, while the colour varies depending on its botanical source (Bonvehí and Coll 2000). Different studies have reported that European propolis (poplar-type) antibacterial activity is attributed to a number of phenolic compounds, mainly flavonoids, phenolic acids and their esters (Bankova et al. 2002). The Brazilian-type propolis is rich in terpenoids and prenylated derivatives of p-coumaric acid (Da Silva et al. 2006), and polyisoprenylated benzophenones in Cuban propolis (Cuesta-Rubio et al. 2002). The substance is sticky at and above room temperature and is used by bees as a glue and general purpose sealant. The antimicrobial property of propolis has been widely reported to be responsible for the low incidence of bacteria and moulds within hives (Marcucci 1995). Its antiseptic properties keep the hives healthy. Synergism between propolis and antibacterial agents has been observed, and the bacteriostatic effect is reflected in its constituent, which may differ from area to area and from season to season, according to different plant sources (Drago et al. 2000; Cuesta-Rubio et al. 2002; Boyanova et al. 2005). Most of the antifungal research into propolis has concentrated mainly on yeasts, such as different species of Candida, or dimorphic human and animal pathogenic fungi, with satisfactory fungistatic and fungicidal results in both in vitro and in vivo experiments (Sawaya et al. 2002). Filamentous fungi are generally less sensitive to propolis activity than bacteria and yeasts, regardless of the origin or composition of the propolis. It is well established that the antibacterial, antifungal and anti-inflammatory properties of propolis are due to the existence of low-molecular-weight compounds of diverse polarity, such as phenolic compounds (flavonoids, phenolic acids and their esters), distributed in glycosides of anthocyanidines, flavones, flavonols, and flavanones in nature with aromatic acids (e.g., caffeic acid and p-coumaric acids) (Bonvehí and Jordà 1995; Hegazi et al. 2000; Kalogeropoulos et al. 2009).
Compounds which are identified in propolis are generally typical constituents of food/or food additives, and have gained a significant position in recent years as GRAS (Generally Recognized As Safe) products (Burdock 1998). In a previous paper, it was also reported that propolis exerted antimicrobial activity on Gram-positive bacteria, but had a limited response with Gram-negative bacteria (Mohammadzadeh et al. 2007; Tosi et al. 2007). However, its biological properties may vary according to different plant sources (Bankova et al. 2000). The chemical composition and biological activity of propolis has been studied extensively in many European countries (Kosalec et al. 2003; Uzel et al. 2005; Popova et al. 2009), but only a few reports can be found on Spanish propolis (Bonvehi and Gutiérrez 2011). Based on these observations, this study aimed to measure the antibacterial activity of propolis extracts (prepared with ethanol and propylene glycol) against Gram-positive bacteria (S. mutans, S. pyogenes and S. aureus), Gram-negative bacteria (H. pylori, S. enterica and E. coli) and fungi strains (C. albicans and S. cerevisae).
Materials and methods
Propolis samples
In this study, 19 samples of raw propolis produced by Apis mellifera honeybees were collected from apiaries located in naturally preserved areas of the Basque Country (Bizkaia, Gipuzkoa and Araba) (Fig. 1). Propolis samples were collected from the same apiary from spring to winter (2005 and 2008) employing the frame-scraping technique described in the Basque Apicultural Programme protocol.
Pollen grains may be introduced into propolis by worker bees during manufacture, and may stem from bee loads from anemophilous plant species. The palynological processing of samples was determined according to Barth (1998). The main plant species visited that contributed to the propolis were: poplar [Populus sp. (Aigeros section], ash (Fraxinus sp.), elm (Ulmus sp.), willow (Salix sp.), chestnut (Castanea sativa), blackberry (Rubus ulmifolius), oak (Quercus sp.), and birch (Betula sp.)]. Representative samples were collected (500 g) and sent to the laboratory with the corresponding collection and location data (Table 1). After harvesting and prior to analysis, macroscopic impurities were removed. Two to three sub-samples from different parts of each lot were then taken to create the 50 g samples. The samples, previously cooled at −20°C for 24 h, were milled in an IKA A 10 analytical mill (LabSource, UK). The resulting product was packaged in foil, with 25 g being used as a control sample and 25 g being stored in darkness at 4°C, to carry out different assays. Samples were either homogenized or pulverized if necessary and analysed in triplicate.
Preparation of ethanolic and propylene glycol extracts of propolis
For the evaluation of the antimicrobial activity, the active compounds were extracted from 20 g of finely ground propolis with 70% ethanol or 100% propylene glycol (100 ml), with intermittent manual shaking, at room temperature in the dark for a week. The insoluble fraction was separated by filtration. The filtrate was then taken up to 100 ml with the corresponding solvent, and stored in sealed bottles at 4°C for 1 week. All extracts were kept in the dark, at room temperature prior to antibacterial testing. Their composition is shown in Table 2.
Reagents and standards
Ethanol and propylene glycol were analytical grade and supplied by Panreac (Barcelona, Spain), and phenol was obtained from Sigma-Aldrich (Steinheim, Germany).
Strain and culture conditions
Bioassays of the antimicrobial activities of the Basque propolis were performed using (a) three species of Gram-positive bacteria (Streptococcus mutans CECT 479T, Staphylococcus aureus CECT 435 and Streptococcus pyogenes CECT 191); (b) three species Gram-negative bacteria (H. pylori CIP 103995, Salmonella enterica CIP 6062 and Escherichia coli CECT 101); and (c) two yeasts species (Candida albicans CECT 1394 and Saccharomyces cerevisae CECT 1383). The indicator organisms were procured from the Spanish collection of microorganisms and cell cultures [The Spanish Type Culture Collection (CECT) is a general service of the University of Valencia, Spain], and the Institute Pasteur Collection (CIP). Microbiological media were purchased from Oxoid Ltd (Basingstoke, UK) and Biolife (Milan, Italy).
Determination of antimicrobial activities
Antimicrobial activity evaluated by the agar diffusion method
The agar well diffusion method was used to determine the antimicrobial activities of EEP and PEP (modified Kirby-Bauer method). The inoculum was prepared from pure cultures, incubated in selective media [C. albicans (Sabouraud 4% glucose agar), E. coli (tryptone soy agar), S. mutans (brain–heart infusion), S. aureus (trypticase soy broth), S. cerevisae (yeast extract-peptone-trehalose), S. enterica (tryptone soy agar), S. pyogenes (brain–heart infusion) and H. pylori (Columbia agar with defibrinated horse blood)] for 24 h. All types of media were sterilized to autoclaving at 121°C and 1.03 bars for 15 min. The inoculum size was adjusted so as to deliver final inoculums of approximately 108 colony forming units (c.f.u.)/ml, equivalent to McFarland 0.5 standard. One millilitre of the cellular suspension obtained was added to 10 ml of previously melted Mueller–Hinton agar, mixed, poured into Petri dishes and left to solidify for 1 h. A sterile punch was used to make 8 mm-diameter staggered wells in the solidified agar. Forty microliter EEP or PEP were added in peripheral holes and 40 μl 70% ethanol of 100% propylene glycol was added in the central hole for negative control. Incubation was performed at 37°C for 24 h. Antimicrobial activity was based on measurement of the diameter of the inhibition zone formed around the well, and the effect was calculated as the mean of the triplicate determinations. The measurement was compared to the criteria set by the European Committee on Antimicrobial Susceptibility Testing (EUCAST 2011). Based on the criteria, the organism can be classified as being Resistant (R), Intermediate (I) or Susceptible (S).
Determination of the minimum inhibitory concentration (MIC)
The MIC was defined as the lowest solution concentration that inhibited at least 90% of the microorganism growth after incubation. The antibacterial activity was assayed by the agar-well diffusion method proposed by Allen et al. (1991), with minor modifications. Solid media containing different concentrations of EEP or PEP were used (0.025–2%, v/v). In addition, concentrations of 1, 5 and 10% were incorporated into the media for bacterial strains that were insensitive to the lower concentrations. Phenol aqueous standard solutions from 1 to 10% (w/v) were prepared to use as comparative standards. All samples were prepared aseptically, assayed immediately after dilution, and were handled away from direct sunlight.
The cellular suspension (1.5 × 108 c.f.u./ml) was diluted in sterile physiological saline solution to a concentration of 106 c.f.u./ml. Large square plates (125 × 125 × 15 mm) seeded with the different microorganisms were prepared by adding 100 μl aliquots of each prepared microbial suspension to 150 ml of sterilized Mueller–Hinton agar cooled to 45°C. Candida albicans required an additional glucose solution of 10% to the nutrient agar, with a final concentration of 1/‰. The plates were poured on a level surface immediately after mixing, and stored at 4°C overnight before use the next day. Twenty-five wells were cut in the agar using a cooled flamed 8 mm cork borer, and using a quasi-Latin square as a template. The wells were numbered, and the samples were tested in triplicate, by adding 80 μl of the solution of propolis to each of three cells with the same number. The plates containing microorganisms were incubated at 37°C for 24 h, under aerobic conditions. After incubation, confluent microbial growth was observed. The diameter of the clear zones was measured using a ruler and compared with those obtained with different phenol concentrations. A standard graph was plotted representing the percentage of phenol against the square of the mean diameter of the clear zone. The MICs of each strain were expressed as the lowest propolis concentration of the sample that caused a clear (1–3 mm) zone of inhibition. All MICs were determined in triplicate at all dilutions.
Statistical analysis
Analysis of variance (ANOVA) was applied to determine significant differences among the geographical origins of the samples analysed. ANOVA was performed according to the fixed factor model, considering locality, year, and antimicrobial activity as sources of variation, using F distribution and unpaired Student’s test at a level of P ≤ 0.05. Pearson correlation was used in order to verify a possible correlation between flavonoid content and antimicrobial activity of EEP and PEP extracts. The results were analysed by means of Statistica software for Windows 5.5 (StatSoft Inc., Tulsa, OK, USA). The mean of three replicates was taken as the variation limit for each parameter.
Results and discussion
Antimicrobial activity
As a general rule, an extract was considered as active against both bacteria and fungi if the zone of inhibition was greater than 6 mm. The inhibition diameters obtained in the different samples are shown in Table 3. The largest inhibition zones were noticed against H. pylori (from 13 to 20 mm), S. enterica (from 10 to 18 mm), and S. aureus (from 10 to 16 mm). The results obtained agreed with those of Boyanova et al. (2005), who observed inhibition zones ≥15 mm for H. pylori. Similarly, the antimicrobial activity of Brazilian propolis at 30% of concentration against H. pylori was also determined by using the agar-well diffusion method and the inhibition zone diameter was established at 21.4 mm (Kimoto et al. 1998).
On the other hand, medium-size inhibition zones were recorded against S. pyogenes and S. mutans (from 4 to 12 mm), and less fungicidal activity was shown against C. albicans and S. cerevisae (from 4 to 10 mm). With most of the samples tested, the diameter of the inhibition zones ranged between 8 and 14 mm against bacterial species and the extracts considered more active presented an inhibition zone diameter from 15 to 20 mm (Table 3). This variation may be correlated to the chemical composition of the propolis. This explanation was supported by Bonvehi and Gutiérrez (2011), when they found that the antioxidant activity of Basque propolis differed according to differences in phenolic compositions. European researchers support different flavonoid aglycones as the antibacterial agents in propolis (Bonvehí et al. 1994; Bankova et al. 2000). Tetracycline and ampicillin showed an antibacterial activity with inhibition diameters between 22 and 32 mm against S. aureus and E. coli (Table 3). The control (ethanol 70% and propylene glycol 100%, v/v) showed no inhibitory zone against any bacteria or fungi tested. The data reported in the literature reveals that propolis samples from Brazil showed inhibition diameters against S. aureus within the 8–13 mm range (Gonsales et al. 2006), comparable with results obtained by Prytzyk et al. (2003) from Bulgarian propolis. Argentinean propolis measured inhibition zones of over 10 mm for S. aureus and of under 10 mm for S. pyogenes (Nieva Moreno et al. 1999). Chinese and Japanese propolis gives inhibition zones ranging from 5.5 to 6.8 mm for S. mutans (Ikeno et al. 1991). Stepanovi et al. (2003) discovered that the inhibition zone of propolis from different locations of Serbia ranged from 18 to 23 mm. These results are in the same range as those reported in this study, but the literature indicates that the sensitivity of microorganisms and differences in the active compounds of propolis that possess antibacterial and antifungal activities are greatly affected by variations in geographical origins (Bankova et al. 2000). The low sensitivity detected for E. coli was in agreement with several publications, where it was concluded that this bacterium showed very low susceptibility to the bactericidal action of propolis (Kujumgiev et al. 1999; Nieva Moreno et al. 1999; Bonvehí and Coll 2000). The most plausible explanation for the lack of sensitivity shown by Gram-negative bacteria could be attributed to their outer membrane that inhibits and/or retards the penetration of propolis at lower concentrations, but this effect is as yet not fully explained. Another possible reason might be the presence of multidrug resistance pumps (MDRs), which extrude amphipathic toxins across the outer membrane (Tegos et al. 2002). Furthermore, results of tests evaluating propolis from other parts of the world could be difficult to compare because by the low hydro-solubility of active compounds in the agar layer (Sawaya et al. 2004).
The results of MIC’s against different microbial agents are shown in Table 4. These values were determined by the agar-well diffusion method, applying breakpoint tables for their interpretation (EUCAST 2011). According to the results obtained, all the Gram-positive bacteria tested were highly sensitive to a lower concentration of propolis (MIC ranged between 0.6 and 1.3 mg/ml) especially against S. mutans and S. aureus, exhibiting a moderate effect on S. pyogenes (MIC ranged between 17 and 26 mg/ml). Escherichia coli displayed a negligible inhibition by most of the EEP and PEP samples, and was insensitive at any of the concentrations tested (1–100 mg/ml). Different researchers reported that propolis had no effect on standard E. coli (Kujumgiev et al. 1999; Stepanovi et al. 2003; Gonsales et al. 2006). In contrast to this strain, the samples showed efficient antibacterial action against S. enterica (MIC ranged between 0.6 and 1.4 mg/ml) and H. pylori (MIC ranged between 6 and 14 mg/ml) such as Gram-negative bacteria. As Table 4 shows, in the antifungal assay, EEP/PEP showed a strong sensitivity against C. albicans and S. cerevisae (MIC ranged between 0.6 and 1.5 mg/ml). However, it was found that a concentration of 15–30 mg/ml of propolis was needed to inhibit the growth of C. albicans (Pepeljnjak et al. 1982). No significant differences were detected between EEP/PEP extracts and years of collection (P \({\leqslant}\) 0.05).
These results are in the same range as those reported with Brazilian propolis (Santos et al. 2002). Sonoran propolis (collected in northwestern Mexico) showed very high growth-inhibitory activity towards Gram-positive bacteria, particularly against S. aureus (MIC of 0.1 mg/ml) (Velazquez et al. 2007). According to Hegazi et al. (2000), Austrian propolis has exhibited high activity against C. albicans and German propolis has been very active against S. aureus and E. coli. This difference in the MIC values of propolis was related to the different constituents of propolis collected from different geographical regions (Bankova et al. 2000). The results of this work, as well as the results of other authors, indicate that agar-well diffusion is an appropriate method for evaluating the antimicrobial activity of solvent propolis samples.
Variations in the flavonoid content of propolis were mainly due to the difference in the preferred regional plants visited by honeybees and also to the raw propolis cleaning and extraction process (Ahn et al. 2007; Bonvehi and Gutiérrez 2011). In previous study, the amounts of total phenolic content and flavonoid contents (flavones and flavanones) determined in Basque propolis varied widely and ranged from 200 to 340 and 72–161 mg/g, respectively (Bonvehi and Gutiérrez 2011). They also varied according to the geographic regions. Furthermore, all the results confirmed that the extracts analysed possessed strong antioxidant activity in the different free radicals studied, and flavonoid compounds are the best candidates to assessing the quality of Basque propolis, due to their different biological properties and predominance in the phenolic fraction. Similarly, the higher the content of phenolic and flavonoids compounds, the more active was the antimicrobial activity detected in the samples analysed (Tables 2 and 4).
In general the strong antimicrobial activity of Basque propolis may be because of the presence of diverse phytochemical compounds, mainly flavonoids, this confirming the traditional reputation of propolis as a powerful antibacterial agent. Flavonoids and esters of phenolic acids are normally associated with the antibacterial activity of bee glue (propolis origin, honeybee species and extract preparation), especially in European propolis (Kosalec et al. 2003, 2004; Boyanova et al. 2005; Popova et al. 2009). However, although tropical propolis does not contain these kinds of compounds, they show similar antibacterial activity and this suggests that synergy between different compounds is essential for its biological activity (Kujumgiev et al. 1999).
Recently, we found that the flavonoid levels of aged propolis were 20% lower that those in fresh propolis, and that some labile propolis compounds are highly degraded (Bonvehí and Coll 2000). Thus, antibacterial activity was proposed as a quality criterion for propolis freshness (Dolci and Ozino 2003; Mohammadzadeh et al. 2007) and a significant negative correlation between the amount of total flavonoids and MIC value was observed in this study. The results showed that all extracts (i.e., EEP and PEP) of Basque propolis tested were very active, and the samples with highest total phenolic content also showed the best antimicrobial activity. We can conclude from this study that Basque propolis extracts show antimicrobial activity that acts mainly on Gram-positive bacteria and yeasts, having a positive correlation with flavonoid content.
References
Ahn MR, Kumazawa S, Usui Y, Nakamura J, Matsuoka M, Zhu F, Nakayama T, Nakaya T (2007) Antioxidant activity and constituents of propolis collected by various areas of China. Food Chem 101:1383–1392
Allen KL, Molan PC, Reid GM (1991) A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43:817–822
Bankova V, Marcucci MC, Castro SL (2000) Propolis: recent advances in chemistry and plant origin. Apidologie 31:3–15
Bankova V, Popova M, Bogdanov S, Sabatini AG (2002) Chemical composition of European propolis: expected and unexpected results. Z Naturforsch 57c:530–533
Barth OM (1998) Pollen analysis of Brazilian propolis. Grana 37:97–101
Bonvehí JS, Coll FV (2000) Study of propolis quality from China and Uruguay. Z Naturforsch 55c:778–784
Bonvehi JS, Gutiérrez AL (2011) Antioxidant activity and total phenolics of propolis from the Basque Country (Northeastern Spoain). J Am Oil Chem Soc 88:1387–1395
Bonvehí JS, Jordà RE (1995) Studie über die bacteriostatische aktivität von propolis. Dtsch Lebensm Rundsch 91:242–246
Bonvehí JS, Coll FV, Jordà RE (1994) The composition, active components and bacteriostatic activity of propolis in dietetics. J Am Oil Chem Soc 71:529–532
Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N, Mitov I, Krastev Z (2005) Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J Med Microbiol 54:481–483
Burdock GA (1998) Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol 36:347–363
Cuesta-Rubio O, Frontana-Uribe BA, Ramirez-Apan T, Cardenas J (2002) Polyisoprenylated benzophenones in Cuban propolis: biological activity of activity of nemorosone. Z Naturforsch 57c:372–378
Da Silva JF, Sourza MC, Ramalho Matta SR, Ribeiro de Andrade M, Nova Vidal FV (2006) Correlation analysis between phenolic levels of Brazilian propolis extracts and their antimicrobial and antioxidant activities. Food Chem 88:431–435
Dolci P, Ozino OI (2003) Study of the in vitro sensitivity to honey bee propolis of Streptococcus aureus strains characterized by different sensitivity to antibiotics. Ann Microbiol 53:233–243
Drago L, Monbelli B, De Vecchi E, Fassina MC, Tocalli MP, Goirmondo MR (2000) In vitro antimicrobial activity of propolis dry extract. J Chemother 12:390–395
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2011) European society of clinical microbiology and infectious diseases (www.eucast.org)
Gonsales GZ, Orsi RO, Fernandes Júnior A, Rodrigues P, Funari SR (2006) Antibacterial activity of propolis collected in different regions of Brazil. J Venom Anim Toxins Incl Trop Dis 12:276–284
Hegazi AG, Hady FK, Alloh FA (2000) Chemical composition and antimicrobial activity of European propolis. Z Natursforsch 55c:70–75
Ikeno K, Ikeno T, Miyazawa C (1991) Effects of propolis on dental caries in rats. Caries Res 25:347–351
Kalogeropoulos N, Konteles SJ, Troullidou E, Mourtziunos I, Karathanos VT (2009) Chemical composition, antioxidant activity and antimicrobial properties of propolis extracts from Greece and Cyprus. Food Chem 116:452–461
Kimoto T, Aral S, Kohgucci M, Aga M, Nomura Y, Micallef MJ, Kurimoto M, Mito K (1998) Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis. Cancer Detect Prev 22:506–515
Kosalec I, Bakmaz M, Pepeljnjak S (2003) Analysis of propolis from the continental and Adriatic regions of Croatia. Acta Pharm 53:275–285
Kosalec I, Bakmaz M, Pepeljnjak S, Knezevi SV (2004) Quantitative analysis of the flavonoids in raw propolis from northern Croatia. Acta Pharm 54:65–72
Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Chrostov R, Popov S (1999) Antimicrobial, antifungal and antiviral activity of propolis of different geographic origin. J Etnopharmacol 64:235–240
Marcucci MC (1995) Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26:83–99
Mohammadzadeh Sh, Shariatpanahi M, Hamedi M, Ahmadkhaniha R, Samadi N, Ostad SN (2007) Chemical composition, oral toxicity and antimicrobial activity of Iranian propolis. Food Chem 103:1097–1103
Nieva Moreno MI, Isla MI, Cudmani NG, Vattuone MA, Sampietro AR (1999) Screening of antibacterial activity of Amaicha del Valle (Tucuman, Argentina) propolis. J Ethnopharmacol 68:97–102
Pepeljnjak S, Maysinger D, Jalsenjak I (1982) Effect of propolis extract on some fungi. Scientia Pharmaceutica 50:165–167
Popova M, Chinou IB, Marekov IN, Bankova VS (2009) Terpenes with antimicrobial activity from Cretan propolis. Phytochem 70:1262–1271
Prytzyk E, Dantas AP, Salomao K, Pereira AS, Bankova VS, De Castro DL, Netro FRA (2003) Flavonoids abnd trypanocidal activity of Bulgarian propolis. J Ethnolpharmacol 88:189–193
Santos FA, Bastos EM, Uzeda M, Carvalho MA, Farias LM, Moreira ES, Braga FC (2002) Antibacterial activity of Brazilian propolis and fractions against anaerobic bacteria. J Ethnopharmacol 80:1–7
Sawaya AC, Palma AM, Caetano FM, Marcucci MC, da Silva Cunha IB, Araujo CE, Shimizu MT (2002) Comparative study of in vitro methods used to analyse the activity of propolis extracts with different compositions against species of Candida. Lett Appl Microbiol 35:203–207
Sawaya AC, Souza KS, Marcucci MC, Cunha IB, Shimizu MT (2004) Analysis of the composition of Brazilian propolis extracts by chromatography and evaluation of their in vitro activity against Gram-positive bacteria. Braz J Microbiol 35:104–109
Stepanovi S, Anti N, Daki I, Vlahovi M (2003) In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol Res 158:353–357
Tegos G, Stermitz FR, Lomovskaya O, Lewis K (2002) Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother 46:3133–3141
Tosi EA, Ré E, Ortega ME, Cazzoli AF (2007) Food preservative based on propoli: bacteriostatic activity of propolis polyphenols and flavonoids upon Escherichia coli. Food Chem 104:1025–1029
Uzel A, Sorkun K, Oncag O, Cogulu D, Gencay M, Salih B (2005) Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol Res 160:188–195
Velazquez C, Navarro M, Acosta A, Angulo A, Dominguez Z, Robles R, Robles-Zepeda R, Lugo E, Goycolea PM, Velazquez EF, Astiazaran H, Hernandez J (2007) Antibacterial and free-radical scavenging activities of Sonoran propolis. J Appl Microbiol 103:1747–1756
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bonvehí, J.S., Gutiérrez, A.L. The antimicrobial effects of propolis collected in different regions in the Basque Country (Northern Spain). World J Microbiol Biotechnol 28, 1351–1358 (2012). https://doi.org/10.1007/s11274-011-0932-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-011-0932-y